Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) EBT Margin: 2013-2025

Historic EBT Margin for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Sep 2025 value amounting to 11.21%.

  • Amphastar Pharmaceuticals' EBT Margin fell 1372.00% to 11.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.51%, marking a year-over-year decrease of 782.00%. This contributed to the annual value of 26.66% for FY2024, which is 157.00% down from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its EBT Margin stood at 11.21% for Q3 2025, which was down 50.28% from 22.55% recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year EBT Margin high stood at 38.83% for Q4 2022, and its period low was 4.96% during Q1 2021.
  • Its 3-year average for EBT Margin is 24.51%, with a median of 24.94% in 2024.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' EBT Margin spiked by 2,950bps in 2021 and then tumbled by 1,474bps in 2022.
  • Amphastar Pharmaceuticals' EBT Margin (Quarterly) stood at 22.47% in 2021, then spiked by 1,636bps to 38.83% in 2022, then crashed by 968bps to 29.14% in 2023, then slumped by 267bps to 26.47% in 2024, then plummeted by 1,372bps to 11.21% in 2025.
  • Its EBT Margin stands at 11.21% for Q3 2025, versus 22.55% for Q2 2025 and 18.10% for Q1 2025.